Skip to Content

'
Steven H. Lin, M.D., Ph.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2004 University of California, Irvine, CA, MD, Medicine
2004 University of California, Irvine, CA, PHD, Pharmacology
1995 University of California, Riverside, CA, MS, Biochemistry
1994 University of California, Riverside, CA, BS, Biology
1992 California Polytechnic University, Pomona, CA, BA, Architecture (transferred)

Postgraduate Training

7/2005-8/2009 Clinical Residency, The John Hopkins Hospital, Baltimore, MD
7/2004-6/2005 Clinical Internship, Internal Medicine, Loma Linda University Medical Center, Loma Linda, CA
6/2001-7/2002 Post-Ph.D., Neogene Technologies, Irvine, CA

Board Certifications

8/2009 American Board of Radiology (pending)

Honors and Awards

2008-2009 RSNA Research Resident Grant
2008 ABS/Nucletron HDR Brachytherapy Fellowship
2004 Alpha Omega Alpha, University of California, Irvine School of Medicine
2001 Henry Wood Elliott Award in Pharmacology
1998 American Heart Association Medical Student Fellowship
1997 UC Regents Research Fellowship
1996-1997 Dean's Award, University of California, Irvine School of Medicine
1996 Donald E. Pinder, M.D. Memorial Award
1996 Dr. Grace Bell Award
1995-2004 Medical Scientist Training Program Fellowship and Stipend
1994 Phi Beta Kappa, University of California
1994 Summa Cum Laude, University of California

Selected Publications

Peer-Reviewed Original Research Articles
1. Lin SH, Rudra S, Swartz MJ, Schulick TJR, Winter J, Laheru D, Pawlik TM, Frassica D, Herman JM. Concurrent Gemcitabine and radiotherapy for locally advanced pancreatic cancer: The effect of field of size on safety and tolerability of treatment. Radiation Oncology. In Press.
2. Hristov B, Hristov A, Lin SH, Arceci RJ, Wharam MD. Cutaneous langerhans cell histiocytosis treated successfully with radiation. Journal of Clinical Oncology. In Press.
3. Tan AC, Jimeno A, Lin SH, Wheelhouse C, Chan F, Solomon A, Rubio-Viqueria B, Hidalgo M. Characterizing DNA methylation patterns of pancreatic cancer genome. Molecular Oncology. e-Pub 4/2009.
4. Hristov B, Reddy S, Lin SH, Cameron JL, Herman JM, Pawlik TJ, Hruban RH, Swartz MJ, Edil BH, Kemp C, Wolfgang CL. Outcomes of adjuvant chemoradiation following pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phy. e-Pub 4/2009.
5. Lin SH, Latronico D, Teslow T, Bajaj G. A highly reproducible bolus immobilization technique for the treatment of scalp malignancies. Medical Dosimetry 33(1):30-35, 2008.
6. Yi JM, Tsai HC, Glockner SC, Lin SH, Ohm J, Waswaran H, James CD, Costello JF, Riggins G, Eberhart CG, Laterra J, Vescovi AL, Ahuja N, Herman JG, Schuebel KE, Baylin SB. Abnormal DNA methylation of CD133 in Colorectal and Glioblastoma Tumors. Cancer Research 68(19):8094-8103, 2008.
7. Lin SH, Kleinberg LK. Carmustine Wafers: Localized delivery of chemotherapeutic agents in CNS malignancies. Expert Rev Anticancer Ther 8(3):343-359, 2008.
8. Lin SH, Sugar E, Teslow T, McNutt T, Saleh H, Song DY. Comparison of daily couch shifts using MVCT (TomoTherapy) and B-mode Ultrasound (BAT system) during prostate radiotherapy. Technol Cancer Res Treat 7(4):279-286, 2008.
9. Lin Sh. Prolactin Releasing Peptide. Results Probl Cell Differ 19, 2008.
10. Jackson VR, Lin SH, Wang Z, Nothacker HP, Civelli O. A study of the rat neuropeptide B/neuropeptide W system using in situ techniques. J Comp Neurol 497(3):367-383, 2006.
11. Nagasaki H, Wang Z, Jackson CR, Lin SH, Nothacker HP, Civelli O. Differential expression of the thyrostimulin subunits, glycoprotein alpha2 and beta5 in the rat pituitary. J Mol Endocrinol 37(1):39-50, 2006.
12. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L, Civelli O. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43(4):487-497, 2004.
13. Lin SH, Civelli O. Orphan G protein-coupled receptors: targets for new therapeutic interventions. Ann Med 36(3):204-214, 2004.
14. Lin SH, Leslie FM, Civelli O. Neurochemical properties of the PrRP receptor expressing neurons: Evidence for a role as a regulator of stress and nociception. Brain Res 952:15-30, 2002.
15. Lin SH, Arai A, Espana RA, Berridge CW, Leslie F, Hugenard J, Vergnes M, Civelli O. Prolactin Releasing Peptide (PrRP) promotes waking and suppresses absence seizures. Neuroscience 114:229-238, 2002.
16. Civelli O, Nothacker HP, Saito Y, Wang Z, Lin SH, Reinscheid RK. Novel neurotransmitters as natural ligands of orphan G protein-coupled receptors. Trends in Neuroscience 24:230-237, 2001.
17. Lin SH, Arai A, Wang Z, Nothacker HP, Civelli O. The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in a-amino3- hydroxy-5-methylisoxazole-4-propionic acid receptor clustering. Mol Pharmacol 60:916-924, 2001.
18. Nothacker HP, Wang Z, Zhu Y, Reinscheid RK, Lin SH, Civelli O. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol Pharmacol 58(6):1601-1608, 2000.
19. Saito Y, Nothacker HP, Wang Z, Lin SH, Leslie F, Civelli O. Molecular characterization of the melanin-concentrating hormone receptor. Nature(400):265-269, 1999.

Last updated: 9/17/2009